Techinical.ly: The research park’s perfectly matched location and array of startup-supporting resources makes it an invaluable pillar for a growing number of life science startups – and the entire Maryland ecosystem.
Streaming now on The Commons Podcast: Host, Thomas Osha of Wexford Science & Technology LLC sits down with KaloCyte CEO Elaine Haynes in the company’s lab at the University of Maryland, Baltimore (UMB) and University of Maryland BioPark to discuss their...
TEDCO Invests SSBCI Funding into Kalocyte, Inc. July 17, 2023 TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 State Small Business Credit Initiative (SSBCI) investment into KaloCyte, Inc. This investment came through TEDCO’s...
Governor Moore Focuses on Jobs, Economy in Fifth Bill Signing May 8, 2023 Moore compared the bill to public sector grant funding that went to companies such as KaloCyte. The Baltimore-based company is working to develop an artificial red blood cell substitute...
Penn State Scientist Plays Key Role in $46M Artificial Blood Research Program Mar. 27, 2023 Penn State Professor Dipanjan Pan co-invented ErythroMer, an artificial oxygen carrier, that will be used in a $46 million project led by the University of Maryland School of...
AABB News: Biosynthetic Components Come Together in Search for Whole Blood Substitutes Mar. 20, 2023 Transfusion medicine is dependent upon altruistic blood donors, the time of year, geography, screening and testing time, storage limitations and the logistics of...
